Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.

Ando M, Hoyos V, Yagyu S, Tao W, Ramos CA, Dotti G, Brenner MK, Bouchier-Hayes L
Cancer Gene Ther. 2014 Nov;21(11):472-82. doi: 10.1038/cgt.2014.53. Epub 2014 Oct 17. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.